The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”

Synthesis process of Kylo-0603. by Xueqin lu (22250795)

“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”

ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”

Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. by Xueqin lu (22250795)

General procedure for the synthesis of B. by Xueqin lu (22250795)

Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

The body weight and cholesterol levels of the mice were recorded before the administration of the drug. by Xueqin lu (22250795)

The trends of cholesterol metabolism-related gene expression in liver tissue. by Xueqin lu (22250795)

Kylo-0603’s EC50 & tissue levels. by Xueqin lu (22250795)

DIO Mice Liver Staining. by Xueqin lu (22250795)

The Fibrosis scoring by Sirius Red staining and SHG/TPEF. by Xueqin lu (22250795)

Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... by Xueqin lu (22250795)

Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine... by Xueqin lu (22250795)

General procedure for the synthesis of Kylo-0603. by Xueqin lu (22250795)

Results of cost-effectiveness analysis of <i>Chuna</i> manual therapy compared with usual care^a. by Jae-Heung Cho (798319)

Subcellular Mechanical Imaging of Erythrocytes with Optically Correlated Scanning Ion Conductance Microscopy by Yunong Wang (10358970)

“…Comparison of normal and diamide-treated red blood cells shows a significant increase in cell stiffness and a concomitant decrease in deformability, clearly demonstrating the quantitative abilities of the correlative approach taken here for stiffness measurements of intact cellular samples.…”